# First Choice Healthcare Solutions, Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/First Choice Healthcare Solutions, Inc.).

## Overview

First Choice Healthcare Solutions, Inc. is a U.S. healthcare services company in transition from its legacy orthopedic and physical therapy business toward a network of functional health and wellness clinics. Its planned model centers on personalized care services such as medical weight loss, hormone replacement, anti-aging, regenerative medicine, and pharmacy services in selected high-growth U.S. markets.

## Products & services

• Medical weight loss programs
• Bio-identical hormone replacement therapy
• Functional medicine and preventive/primary care
• Compounding pharmacy and subscription pharmacy services
• Nutrition coaching and customized meal plans
• Anti-aging, wellness, and quality-of-life services

- **Functional health clinics** (45%) — Clinic-based personalized care services including preventive care, functional medicine, hormone therapy, and wellness treatments.
- **Medical weight loss** (20%) — Prescription-based and programmatic weight management services aimed at obesity reduction and lifestyle improvement.
- **Pharmacy services** (20%) — Compounding and non-insurance pharmacy offerings, including subscription-based pricing for recurring customers.
- **Legacy rehabilitative services** (5%) — Residual orthopedic and physical therapy services that the company plans to terminate over time.
- **Adjunct wellness services** (10%) — Nutrition coaching, diagnostics, behavioral wellness, and medi-spa style offerings that support the core clinic model.

- Medical weight loss programs
- Bio-identical hormone replacement therapy
- Functional medicine and preventive/primary care
- Compounding pharmacy and subscription pharmacy services
- Nutrition coaching and customized meal plans
- Anti-aging, wellness, and quality-of-life services

## Customers

The company targets individuals seeking personalized healthcare beyond standard primary care, especially patients interested in weight loss, hormone optimization, anti-aging, and wellness services. It also serves patients who want recurring pharmacy support and bundled clinic services, often in urban and suburban markets where nurse practitioner-led care is more accepted.

- **Personalized care patients** (primary) — Individuals buying clinic visits and treatment plans for preventive care, functional medicine, and wellness optimization.
- **Medical weight loss patients** (primary) — Patients using prescription and program-based weight management services to address obesity and related health goals.
- **Hormone therapy and sexual health patients** (secondary) — Men and women seeking bio-identical hormone replacement, sexual health, and related specialty care.
- **Pharmacy customers** (secondary) — Recurring users of non-insurance pharmacy and compounded medications, including subscription members.
- **Legacy rehab patients** (emerging) — Residual orthopedic and physical therapy patients served while the company exits its older business model.

- Adults seeking anti-aging, wellness, and quality-of-life services
- Patients pursuing medical weight loss and obesity reduction
- Men and women seeking hormone replacement and sexual health care
- Consumers wanting recurring pharmacy and subscription pricing
- Patients in urban/suburban markets with demand for NP-led care

## Geography

The company is U.S.-focused and is building its next phase around states that allow full practice authority for nurse practitioners. Management specifically highlighted northeast and southwest Florida and Minnesota for initial expansion, with Denver and Phoenix under evaluation for future growth.

- **United States** (100%) — Company operates and plans to expand only in the U.S.

- Business is concentrated in the United States
- Expansion focus includes northeast Florida, southwest Florida, and Minnesota
- Denver and Phoenix are being evaluated for future clinic growth
- Target states are those with full practice authority for nurse practitioners
- Urban and suburban locations matter for patient acquisition and clinic economics

## Strategy

Management is repositioning the company away from legacy orthopedic services and toward a national chain of functional health and wellness clinics. The strategy depends on acquiring or building clinics, repairing referral relationships, reducing costs, and adding pharmacy-led recurring revenue in markets with favorable nurse practitioner rules.

- **Transition to functional health clinics** (short-term) — The legacy orthopedic model has been discontinued and the new model is the basis for future growth.
- **Expand into selected high-growth U.S. markets** (medium-term) — Management wants markets with strong demand and favorable nurse practitioner practice rules.
- **Build recurring pharmacy revenue** (medium-term) — Pharmacy subscriptions and compounded medications can improve repeat business and patient retention.
- **Reduce operating costs and improve cash flow** (short-term) — The company has a going-concern issue and needs lower overhead to fund expansion.

- Exit legacy orthopedic and physical therapy services
- Build a national functional health clinic platform
- Expand first in Florida and Minnesota, then other markets
- Add compounding pharmacy and subscription revenue
- Use digital, referral, and local marketing to acquire patients

## Risks

The company faces substantial execution and financing risk because it is still rebuilding its business model and has limited operating history in the new clinic format. It also faces healthcare-specific risks around regulation, payor relationships, privacy, and pharmacy supply chain reliability, all of which can directly affect patient volume, compliance, and margins.

- **Going-concern and capital access** [critical] — The company has recurring losses and negative operating cash flow, so it may need new equity or debt to fund expansion.
- **Execution risk in new clinic strategy** [high] — Management is pivoting away from a legacy model, and patient acquisition, branding, and clinic economics are unproven at scale.
- **Referral and reputation damage** [high] — The company disclosed prior litigation and reputational harm that affected employees and referral sources.
- **Pharmacy supply chain disruption** [high] — A single compounding pharmacy serving multiple clinics could face ingredient shortages or logistics issues that interrupt service.
- **Healthcare privacy and regulatory compliance** [medium] — HIPAA, HITECH, and state rules govern protected health information and can create penalties and added costs.

- Going-concern and financing risk due to recurring losses and cash burn
- Execution risk in building a new clinic network from a limited base
- Dependence on nurse practitioner staffing and referral relationships
- HIPAA and healthcare privacy compliance risk
- Compounding pharmacy supply chain and regulatory risk

## Accounting

Investors should watch revenue recognition because the company reported very limited revenue and stated that services were discontinued in 2023, making comparability unusual. The balance sheet and earnings are also sensitive to estimates around stock-based compensation, fair value of stock, deferred taxes, and credit losses, while lease and acquisition accounting could become more important as the clinic footprint expands.

- **Revenue recognition and discontinued services** — Makes top-line comparability and run-rate analysis difficult
- **Stock-based compensation and fair value estimates** — Can materially affect operating expenses and net loss
- **Deferred taxes and credit loss allowances** — Can change reported assets, expenses, and equity
- **Lease accounting** — Affects leverage, EBITDA-like metrics, and fixed-cost burden

- Revenue is minimal and affected by service discontinuation and business transition
- Stock-based compensation and fair value estimates can materially affect expenses
- Deferred tax and credit loss allowances rely on management judgment
- Lease accounting will matter as clinic locations expand
- Acquisition accounting may create goodwill or intangible impairment risk

---

*Last updated: 2026-04-28T20:08:15.412983+00:00*